Log in to save to my catalogue

The evidence for repurposing anti-epileptic drugs to target cancer

The evidence for repurposing anti-epileptic drugs to target cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10460753

The evidence for repurposing anti-epileptic drugs to target cancer

About this item

Full title

The evidence for repurposing anti-epileptic drugs to target cancer

Publisher

Dordrecht: Springer Netherlands

Journal title

Molecular biology reports, 2023-09, Vol.50 (9), p.7667-7680

Language

English

Formats

Publication information

Publisher

Dordrecht: Springer Netherlands

More information

Scope and Contents

Contents

Antiepileptic drugs are versatile drugs with the potential to be used in functional drug formulations with drug repurposing approaches. In the present review, we investigated the anticancer properties of antiepileptic drugs and interlinked cancer and epileptic pathways. Our focus was primarily on those drugs that have entered clinical trials with p...

Alternative Titles

Full title

The evidence for repurposing anti-epileptic drugs to target cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10460753

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10460753

Other Identifiers

ISSN

0301-4851

E-ISSN

1573-4978

DOI

10.1007/s11033-023-08568-1

How to access this item